"Performance" SINOMAB BIO-B's annual loss narrowed to 105 million RMB
SINOMAB BIO-B (03681.HK) announced its performance for the fiscal year 2025, reporting a loss of 105 million RMB, compared to a loss of 185 million RMB in the previous year; the loss per share is 0.09 RMB. No final dividend will be distributed. There were no confirmed revenues during the year
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments